Your session is about to expire
← Back to Search
Lifestyle Intervention for Cardiovascular Disease
N/A
Waitlist Available
Led By David S Drozek, DO
Research Sponsored by Ohio University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up yearly for 10 years
Awards & highlights
Summary
The purpose of this study is to evaluate the change in disease prevalence over time in impoverished urban communities in Lima, Peru.
Eligible Conditions
- Cardiovascular Disease
- Dyslipidemia
- Diabetes
- High Blood Pressure
- Obesity
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ yearly for 10 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~yearly for 10 years
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Diastolic Blood Pressure
High density lipoprotein cholesterol
Low-density lipoprotein cholesterol
+5 moreSecondary study objectives
24 hour dietary recall
Exercise vital sign
Herth Hope Index
+3 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Lifestyle InterventionExperimental Treatment1 Intervention
Impoverished communities in Lima, Peru will be offered free medical clinics. Four communities have been chosen initially for focus over the following 10 years. These communities will be made aware of their risk for chronic lifestyle related diseases. In conjunction with the communities, specific interventions focused on a plant-based diet, physical activity, stress management and control of unhealthy habits will be devised.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Lifestyle Modification
2006
Completed Phase 4
~2280
Find a Location
Who is running the clinical trial?
Ohio UniversityLead Sponsor
71 Previous Clinical Trials
36,350 Total Patients Enrolled
David S Drozek, DOPrincipal InvestigatorOhio University
5 Previous Clinical Trials
987 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger